Some Older Breast Cancer Patients Could Skip Radiation

Key points
- Many older women with newly diagnosed breast cancer might safely avoid adjuvant radiation therapy, according to a study reported here.
- You have your treatment in the hospital radiotherapy department.
- The treatment is given in the hospital radiotherapy department as a series of short daily sessions.
- Radiation therapy did not reduce the risk of local recurrence beyond the benefit afforded by tamoxifen alone in women older than 60 with luminal A breast cancer or in women with grade I-II luminal A breast cancer.
Many older women with newly diagnosed breast cancer might safely avoid adjuvant radiation therapy, according to a study reported here.
Radiation therapy did not reduce the risk of local recurrence beyond the benefit afforded by tamoxifen alone in women older than 60 with luminal A breast cancer or in women with grade I-II luminal A breast cancer.
Avoiding radiation therapy in those subgroups could lead to a $400 million savings in healthcare costs, Fei-Fei Liu, MD, reported at the American Association for Cancer Research (AACR) meeting.
"Luminal A lymph node-negative breast cancer is estimated to account for about 25% of all newly diagnosed breast cancer in North America every year," Liu, of the University of Toronto, said during an AACR press briefing. "These patients can avoid unnecessary treatments."
"We estimated a savings of $20 million annually in Ontario if radiation therapy were avoided in early luminal A breast cancer. Extrapolating the figures to the United States resulted in a savings of about $400 million per year," Liu added.
The preferred approach to treating early breast cancer consists of surgery followed by systemic therapy and radiation therapy. Most women can tolerate this approach to treatment, but the therapies can cause side effects, which can be severe in some cases, Liu noted.
Additionally, most radiation therapy schedules are inconvenient and require daily travel, or travel on most days of the week until the treatment is completed. Younger patients also face a risk of secondary malignancies following radiation therapy.
Radiation therapy - also called radiotherapy - is a highly targeted, highly effective way to destroy cancer cells in the breast that may stick around after surgery. Radiation can reduce the risk of breast cancer recurrence by about 70%. Despite what many people fear, radiation therapy is relatively easy to tolerate and its side effects are limited to the treated area.
After breast surgery, radiotherapy can lower the risk of the cancer coming back in the breast.
How and where you have treatment
You have your treatment in the hospital radiotherapy department. You may have treatment once a day, from Monday to Friday, with a rest at the weekend. This means you will have to travel to the hospital every weekday. The course of treatment usually lasts either 3 or 5 weeks.
At your first visit you lie under a CT scanner or a large machine called a simulator. The doctors use this to plan your treatment. You will have one or more small tattoos made on your skin. The radiographers use these to line up the radiotherapy machine accurately each time. You may also have marks drawn on your body with a felt tip pen.
Each treatment only takes a few minutes. The treatment doesn't hurt, and it does not make you radioactive.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsTherapy Found Effective in Older, African American Lung Cancer Patients
University of Cincinnati researchers have found in a phase-2 clinical trial that a Food and Drug Administration-approved therapy could be effective in treating both older and African American patients with advanced lung…
27 November 2014
NewsMost Breast Cancer Patients Who Had Healthy Breast Removed at Peace with Decision
More women with cancer in one breast are opting to have both breasts removed to reduce their risk of future cancer. New research shows that in the long term, most have no regrets. Mayo Clinic surveyed hundreds of women…
26 September 2014
NewsNovel Immunotherapy Vaccine Decreases Recurrence in HER2 Positive Breast Cancer Patients
A new breast cancer vaccine candidate, (GP2), provides further evidence of the potential of immunotherapy in preventing disease recurrence. This is especially the case for high-risk patients when it is combined with a…


